Gene interactions and pathways from curated databases and text-mining

◀ Back to TP53

IGF1R — TP53

Pathways - manually collected, often from reviews:

  • OpenBEL Selventa BEL large corpus: IGF1R → TP53 (decreases)
    Evidence: pIGF-IR (Tyr1131), pIGF-IR (Tyr1135/1136; data not shown), and pAkt (Ser473) levels were obviously higher in HBEC cells expressing p53i and/or RASv12 than in parental HBEC cells (Fig. 2A, right)

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

Text-mined interactions from Literome

Merkle et al., Gene Ther 1998 : Neither wild-type p53 nor p53 delta 326 repressed the transcription of the IGF-1R gene in these cell lines
Girnita et al., Proc Natl Acad Sci U S A 2003 (Melanoma) : One of the challenging questions remaining to be answered is why the wild-type p53 , which per se represses the transcription of the IGF-1R gene, in overexpressed form is necessary for a high IGF-1R expression
Attias et al., Endocr Relat Cancer 2006 (Colonic Neoplasms) : Folic acid and its metabolites modulate IGF-I receptor gene expression in colon cancer cells in a p53 dependent manner
Kavurma et al., Biochem J 2007 (Carotid Stenosis) : Oxidative stress repressed IGF1R expression at multiple levels, and this was also blocked by mutant p53 ... These results suggest that oxidative-stress induced repression of IGF1R is mediated by the association of phosphorylated p53 with the IGF1R promoter via TBP, and by the subsequent recruitment of chromatin modifying proteins, such as HDAC1, to the IGF1R promoter-TBP-p53 complex
Werner et al., Proc Natl Acad Sci U S A 1996 : Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene
Ohlsson et al., Endocrinology 1998 (Osteosarcoma) : p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I induced tyrosine phosphorylation in an osteosarcoma cell line : interaction between p53 and Sp1 ... These data indicate that the IGF-I receptor is a physiological target for p53 in osteosarcoma cells